儿童肿瘤溶解综合征高尿酸血症的诊治进展

doi:10.3969/j.issn.1006-7795.2019.03.030

首都医科大学学报 ›› 2019, Vol. 40 ›› Issue (3): 483-487.doi: 10.3969/j.issn.1006-7795.2019.03.030

儿童肿瘤溶解综合征高尿酸血症的诊治进展

蒋理, 郑胡镛

国家儿童医学中心首都医科大学附属北京儿童医院血液肿瘤中心儿童血液病与肿瘤分子分型北京市重点实验室儿科学国家重点学科儿科重大疾病研究教育部重点实验室, 北京 100045

收稿日期:2018-12-06 出版日期:2019-05-21 发布日期:2019-06-13
通讯作者: 郑胡镛 E-mail:zhenghuyong@bch.com.cn
基金资助:
北京市医院管理局临床医学发展专项经费资助（ZY201404），北京市医院管理局登峰计划（DFL20151101），首都卫生发展科研专项-重点攻关（首发2016-1-2091）。

Progress in diagnosis and treatment of hyperuricemia in children with tumor lysis syndrome

Jiang Li, Zheng Huyong

Beijing Key Laboratory of Pediatric Hematology Oncology;National Key Discipline of Pediatrics(Capital Medical University);Key Laboratory of Major Diseases in Children, Ministry of Education;Hematology Oncology Center, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China

Received:2018-12-06 Online:2019-05-21 Published:2019-06-13
Supported by:
This study was supported by Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Grant (ZY201404),Beijing Municipal Administration of Hospitals Deng Feng Program (DFL20151101),Capital Health and Development of Special Grant (2016-1-2091)

摘要/Abstract

摘要： 高尿酸血症是肿瘤溶解综合征（tumor lysis syndrome，TLS）中的一种严重合并症。尿酸作为人体嘌呤代谢的终产物，在生理条件下主要的存在形式为尿酸盐。血液中的尿酸盐几乎全部被肾小球滤过，而TLS所引起的大量尿酸堆积超过了肾小球的滤过能力，出现"高尿酸血症"。过剩的尿酸随血液到达人体的各个组织器官引起全身性疾病，患者可有恶心呕吐等症状，尿酸沉积在关节和肾脏中可产生关节疼痛及肾绞痛。若高尿酸血症引发急性尿酸盐肾病，则会出现严重的氮质血症和肾功能衰竭。既往只有别嘌呤醇可供临床医生选择用于高尿酸血症的预防，而对已经形成的高尿酸血症并无针对性的药物可以应用。近16年来由于尿酸氧化酶投入市场，临床医生对于预防与治疗TLS所致高尿酸血症的处理变得游刃有余。本文重点对高尿酸血症和尿酸氧化酶的临床应用进展做一综述。

关键词: 肿瘤溶解综合征, 高尿酸血症, 尿酸氧化酶

Abstract: Hyperuricemia is a serious complication of tumor lysis syndrome (TLS). Uric acid is the end product of purine in the human body. Almost all of the uric acid in the blood is filtered by the glomeruli, and the accumulation of uric acid caused by TLS exceeds the capacity of glomeruli, which results in "hyperuricemia". Excessive uric acid reaches tissues and organs with blood and causes systemic disease. Patients may have symptoms such as nausea, vomiting, joint pain and renal colic. If hyperuricemia causes acute urate nephropathy, severe azotemia and renal failure will occur. In the past, only allopurinol was available for pediatricians to prevent hyperuricemia, while there was no specific drug for the established hyperuricemia. In the last 16 years, Due to the use of uric acid oxidase, pediatricians have become more proficient in the prevention and treatment of hyperuricemia caused by TLS. This review focuses on the hyperuricemia and clinical application of uric acid oxidase.

Key words: tumor lysis syndrome, hyperuricemia, uric acid oxidase

中图分类号:

R725.5

蒋理, 郑胡镛. 儿童肿瘤溶解综合征高尿酸血症的诊治进展[J]. 首都医科大学学报, 2019, 40(3): 483-487.

Jiang Li, Zheng Huyong. Progress in diagnosis and treatment of hyperuricemia in children with tumor lysis syndrome[J]. Journal of Capital Medical University, 2019, 40(3): 483-487.

参考文献

[1] Ward E, Desantis C, Robbins A, et al. Childhood and adolescent cancer statistics, 2014[J]. CA Cancer J Clin,2014,64(2):83-103.
[2] Coiffier B, Altman A, Pui C H, et al. Guidelines for the management of pediatric and adult tumor lysis syndrome:an evidence-based review[J]. J Clin Oncol,2008,26(16):2767-2778.
[3] Noone D G, Marks S D. Hyperuricemia is associated with hypertension, obesity, and albuminuria in children with chronic kidney disease[J]. J Pediatr,2013,162(1):128-132.
[4] Cairo M S, Coiffier B, Reiter A, et al. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases:an expert TLS panel consensus[J]. Br J Haematol,2010,149(4):578-586.
[5] Ejaz A A, Pourafshar N, Mohandas R, et al. Uric acid and the prediction models of tumor lysis syndrome in AML[J]. PLoS One,2015,10(3):e119497.
[6] Strauss P Z, Hamlin S K, Dang J. Tumor lysis syndrome:a unique solute disturbance[J]. Nurs Clin North Am,2017,52(2):309-320.
[7] Abu-Alfa A K, Younes A. Tumor lysis syndrome and acute kidney injury:evaluation, prevention, and management[J]. Am J Kidney Dis,2010,55(5 Suppl 3):S1-S13, quiz S14-S19.
[8] Kang D H, Park S K, Lee I K, et al. Uric acid-induced C-reactive protein expression:implication on cell proliferation and nitric oxide production of human vascular cells[J]. J Am Soc Nephrol,2005,16(12):3553-3562.
[9] Cirillo P, Gersch M S, Mu W, et al. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells[J]. J Am Soc Nephrol,2009,20(3):545-553.
[10] Han H J, Lim M J, Lee Y J, et al. Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kappaB[J]. Am J Physiol Renal Physiol,2007,292(1):F373-F381.
[11] Shimada M, Dass B, Ejaz A A. Paradigm shift in the role of uric acid in acute kidney injury[J]. Semin Nephrol,2011,31(5):453-458.
[12] Larosa C, Mcmullen L, Bakdash S, et al. Acute renal failure from xanthine nephropathy during management of acute leukemia[J]. Pediatr Nephrol,2007,22(1):132-135.
[13] Hochberg J, Cairo M S. Tumor lysis syndrome:current perspective[J]. Haematologica,2008,93(1):9-13.
[14] Patte C, Sakiroglu O, Sommelet D. European experience in the treatment of hyperuricemia[J]. Semin Hematol,2001,38(4 Suppl 10):9-12.
[15] Wilson F P, Berns J S. Tumor lysis syndrome:new challenges and recent advances[J]. Adv Chronic Kidney Dis,2014,21(1):18-26.
[16] Finkel K W, Howard S C. Renal disease in cancer patients[M].Massachusetts:Academic Press,2014:39-64.
[17] Goldman S C, Holcenberg J S, Finklestein J Z, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis[J]. Blood,2001,97(10):2998-3003.
[18] Cheuk D K, Chiang A K, Chan G C, et al. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer[J]. Cochrane Database Syst Rev,2017,3:CD006945.
[19] Cairo M S, Thompson S, Tangirala K, et al. A Clinical and economic comparison of rasburicase and allopurinol in the treatment of patients with clinical or laboratory tumor lysis syndrome[J]. Clin Lymphoma Myeloma Leuk,2017,17(3):173-178.
[20] Kikuchi A, Kigasawa H, Tsurusawa M, et al. A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome[J]. Int J Hematol,2009,90(4):492-500.
[21] Syrimi E, Gunasekera S, Norton A, et al. Single dose rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden[J]. Br J Haematol,2018,181(5):696-698.
[22] Yu X, Liu L, Nie X, et al. The optimal single-dose regimen of rasburicase for management of tumour lysis syndrome in children and adults:a systematic review and meta-analysis[J]. J Clin Pharm Ther,2017,42(1):18-26.
[23] Criscuolo M, Fianchi L, Dragonetti G, et al. Tumor lysis syndrome:review of pathogenesis, risk factors and management of a medical emergency[J]. Expert Rev Hematol,2016,9(2):197-208.
[24] Eaddy M, Seal B, Tangirala M, et al. Economic comparison of rasburicase and allopurinol for treatment of tumor lysis syndrome in pediatric patients[J]. Am J Health Syst Pharm,2010,67(24):2110-2114.
[25] Pui C H, Relling M V, Lascombes F, et al. Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies[J]. Leukemia,1997,11(11):1813-1816.
[26] Patte C, Sakiroglu C, Ansoborlo S, et al. Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Societe Francaise d'Oncologie Pediatrique LMB89 protocol[J]. Ann Oncol,2002,13(5):789-795.
[27] Wossmann W, Schrappe M, Meyer U, et al. Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase[J]. Ann Hematol,2003,82(3):160-165.
[28] Patel C, Wilson C P, Ahmed N, et al. Acute Uric acid nephropathy following epileptic seizures:case report and review[J]. Case Rep Nephrol,2019,2019:4890287.

儿童肿瘤溶解综合征高尿酸血症的诊治进展

Progress in diagnosis and treatment of hyperuricemia in children with tumor lysis syndrome

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	杨峥;华琦;邢绣荣;刘荣坤. 高血压患者血尿酸与血脂水平的关系及临床意义[J]. 首都医科大学学报, 2006, 27(3): 369-371.
[2]	张立晶;胡大一;杨进刚;许玉韵;李田昌;王国宏;史旭波;路亚枫. 有心血管疾病危险因素人群中高尿酸血症的发生率及其相关因素[J]. 首都医科大学学报, 2005, 26(2): 124-127.